Stock Events

Omnicell 

$26.57
20
+$0.23+0.85% Friday 20:00

统计数据

当日最高
26.97
当日最低
26.25
52周最高
75.07
52周最低
25.45
成交量
234,736
平均成交量
576,720
市值
1.22B
市盈率
-57.34
股息收益率
-
股息
-

收益

2May已确认
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.09
0.27
0.64
1
预期每股收益
-0.09
实际每股收益
0.03

人们还关注

此列表基于关注OMCL的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

32$平均价格目标
最高估值为 $38。
来自过去6个月内的 2 个评级。这不是投资建议。
买入
50%
持有
50%
卖出
0%

关于

Technology Services
Information Technology Services
Manufacturing
Electronic Computer Manufacturing
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Show more...
首席执行官
Randall Lipps
员工
3590
国家
US
ISIN
US68213N1090
WKN
000632313

上市公司